Israel: Second Subject Enrolled

On May 29, 2013, the second subject was enrolled in our ongoing Israeli study of treating PTSD with MDMA-assisted psychotherapy. This study, led by Clinical Investigator Moshe Kotler, M.D., at Beer Yaakov Mental Hospital, will treat 10 subjects with chronic, treatment-resistant PTSD. In addition to helping develop our treatment methodology, this study is providing comparative data about the effectiveness of MDMA-assisted psychotherapy treatment for PTSD in a new cultural context.